Champions Oncology nets $14 mln
Hackensack, New Jersey-based Champions Oncology Inc, a developer of advanced tech solutions to personalize the use of oncology drugs, has closed $14 million in funding. New Enterprise Associates led the round with participation from other investors that included Battery Ventures, Perceptive Advisors and Sabby Capital. MTS Securities, LLC, an affiliate of MTS Health Partners LP, served as the placement agent.
13 March 2015•3 mins read
